Literature DB >> 23200635

Alternative generation of MHC class II-restricted epitopes: not so exceptional?

Laurence C Eisenlohr1.   

Abstract

By convention, peptides presented at the cell surface by MHC class II molecules (MHCII) are derived from internalized ("exogenous") antigen that is denatured and fragmented in the endocytic compartment and loaded onto MHC in the late endosome with the assistance of the H2-DM chaperone. Over the past two decades several alternatives to this pathway have been described but the extent to which they contribute to natural CD4(+) T cell (T(CD4+))) responses has not been assessed, mainly because studies have focused primarily on individual epitopes. My laboratory has begun to address this issue in virus infection models and a picture is emerging in which classical presentation plays a relatively minor role, with a number of alternative presentation pathways collectively accounting for the majority of peptide presentation. The potential ramifications for this fundamentally altered view of MHCII peptide supply are discussed.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23200635      PMCID: PMC3610803          DOI: 10.1016/j.molimm.2012.10.020

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  8 in total

Review 1.  Autophagy and adaptive immunity.

Authors:  Victoria L Crotzer; Janice S Blum
Journal:  Immunology       Date:  2010-06-25       Impact factor: 7.397

2.  A cytosolic pathway for MHC class II-restricted antigen processing that is proteasome and TAP dependent.

Authors:  Mona K Tewari; Gomathinayagam Sinnathamby; Deepa Rajagopal; Laurence C Eisenlohr
Journal:  Nat Immunol       Date:  2005-02-13       Impact factor: 25.606

Review 3.  Enhancing immunity through autophagy.

Authors:  Christian Münz
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

Review 4.  A modular and combinatorial view of the antigen cross-presentation pathway in dendritic cells.

Authors:  Elodie Segura; José A Villadangos
Journal:  Traffic       Date:  2011-08-16       Impact factor: 6.215

5.  Immunology. The ins and outs of antigen processing and presentation.

Authors:  R N Germain
Journal:  Nature       Date:  1986 Aug 21-27       Impact factor: 49.962

6.  Recognition of intracellular measles virus antigens by HLA class II restricted measles virus-specific cytotoxic T lymphocytes.

Authors:  S Jacobson; R P Sekaly; W J Bellini; C L Johnson; H F McFarland; E O Long
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

7.  Presentation by recycling MHC class II molecules of an influenza hemagglutinin-derived epitope that is revealed in the early endosome by acidification.

Authors:  Gomathinayagam Sinnathamby; Laurence C Eisenlohr
Journal:  J Immunol       Date:  2003-04-01       Impact factor: 5.422

8.  Class II major histocompatibility complex-restricted T cells specific for a virion structural protein that do not recognize exogenous influenza virus. Evidence that presentation of labile T cell determinants is favored by endogenous antigen synthesis.

Authors:  L C Eisenlohr; C J Hackett
Journal:  J Exp Med       Date:  1989-03-01       Impact factor: 14.307

  8 in total
  9 in total

1.  Protein Vaccination Directs the CD4+ T Cell Response toward Shared Protective Epitopes That Can Be Recalled after Influenza Virus Infection.

Authors:  Ajitanuj Rattan; Katherine A Richards; Zackery A G Knowlden; Andrea J Sant
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

2.  Modified vaccinia virus Ankara-infected dendritic cells present CD4+ T-cell epitopes by endogenous major histocompatibility complex class II presentation pathways.

Authors:  Frank Thiele; Sha Tao; Yi Zhang; Andreas Muschaweckh; Tina Zollmann; Ulrike Protzer; Rubert Abele; Ingo Drexler
Journal:  J Virol       Date:  2014-12-17       Impact factor: 5.103

Review 3.  Tetherin/BST-2: Restriction Factor or Immunomodulator?

Authors:  Sam X Li; Bradley S Barrett; Kejun Guo; Mario L Santiago
Journal:  Curr HIV Res       Date:  2016       Impact factor: 1.581

4.  Structural and Nonstructural Viral Proteins Are Targets of T-Helper Immune Response against Human Respiratory Syncytial Virus.

Authors:  Elena Lorente; Alejandro Barriga; Eilon Barnea; Carmen Mir; John A Gebe; Arie Admon; Daniel López
Journal:  Mol Cell Proteomics       Date:  2016-04-18       Impact factor: 5.911

Review 5.  Higher throughput methods of identifying T cell epitopes for studying outcomes of altered antigen processing and presentation.

Authors:  Evan W Newell
Journal:  Front Immunol       Date:  2013-12-05       Impact factor: 7.561

6.  Polarisation of major histocompatibility complex II host genotype with pathogenesis of European Brown Hare syndrome virus.

Authors:  Christos Iacovakis; Zissis Mamuris; Katerina A Moutou; Antonia Touloudi; Anne Sofie Hammer; George Valiakos; Themis Giannoulis; Costas Stamatis; Vassiliki Spyrou; Labrini V Athanasiou; Maria Kantere; Tommy Asferg; Alexios Giannakopoulos; Charlotte M Salomonsen; Dimitrios Bogdanos; Periklis Birtsas; Liljana Petrovska; Duncan Hannant; Charalambos Billinis
Journal:  PLoS One       Date:  2013-09-19       Impact factor: 3.240

Review 7.  Toward a Network Model of MHC Class II-Restricted Antigen Processing.

Authors:  Michael A Miller; Asha Purnima V Ganesan; Laurence C Eisenlohr
Journal:  Front Immunol       Date:  2013-12-16       Impact factor: 7.561

8.  Tetherin/BST-2 promotes dendritic cell activation and function during acute retrovirus infection.

Authors:  Sam X Li; Bradley S Barrett; Kejun Guo; George Kassiotis; Kim J Hasenkrug; Ulf Dittmer; Kathrin Gibbert; Mario L Santiago
Journal:  Sci Rep       Date:  2016-02-05       Impact factor: 4.379

9.  Amino acid signatures in the HLA class II peptide-binding region associated with protection/susceptibility to the severe West Nile Virus disease.

Authors:  Constantina A Sarri; Georgios E Papadopoulos; Anna Papa; Athanasios Tsakris; Danai Pervanidou; Agoritsa Baka; Constantina Politis; Charalambos Billinis; Christos Hadjichristodoulou; Zissis Mamuris
Journal:  PLoS One       Date:  2018-10-31       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.